Theme: Emerging Interventions & Advancements In Treatment Of Diabetes
Diabetes Expo 2015
Omics International invites all the participants across the globe to attend the 6th Global Diabetes Summit and Medicare Expo on November 2-4, 2015 at Dubai, UAE but with the special focus on the theme Emerging Interventions & Advancements In Treatment Of Diabetes. We believe we have chosen a venue that guarantees a successful scientific Conference.
With the success of conference on various clinical, medical and management science, Omics International for the sixth time is going to organize a conference on 6th Global Diabetes Summit and Medicare Expo. The previous five Diabetes congresses were held at Santa Clara-USA, Philadelphia-USA, Hyderabad-India, Chicago-USA and Las Vegas-USA had achieved a grand success. Now it is the time for the diabetes meetings to address new challenges and emerging issues in Diabetes. Diabetes Expo-2015 will also provide the excellent opportunity to meet Physicians, Researchers, Clinicians, Experts, Directors, Professors, Associate Professors, Podiatrists, Pharmacists, Physician assistants, Nurse practitioners, Nurses, Dietitians, Certified diabetes educators, other health care professionals and who manage diabetes related complications.
OMICS International Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. Diabetes congresses 2015 as the number of patients grows across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. diabetes workshops The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. Diabetes events The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. Diabetes expo 2015the fastest-growing segment of oral hypoglycemic drugs manufacturing funding is $14.13 in present scenario of diabetes market.
Clinical Diabetes and Diagnostic Approaches
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels.
Diabetic kidney disease is recognized as the leading cause of excess mortality in the population with type 1 diabetes. The prevailing theory is that excess calories are processed via the mitochondria resulting in accumulation of superoxide radicals via the electron transfer chain. Novel Paradigms in Diabetic Complications, Diabetes, Pre-diabetes represents an elevation of plasma glucose above the normal range but below that of clinical diabetes. Prediabetes and Metabolic Syndrome, To better study both the pathogenesis and potential therapeutic agents, appropriate animal models of type 2 diabetes (T2D) mellitus are needed for Clinical trials on animal models, sodium glucose co-transport inhibitors act as a novel strategy for the treatment of diabetes mellitus
Type 2 diabetes is by far the most common type of diabetes in adults (>90 percent) and is characterized by hyperglycemia and variable degrees of insulin deficiency and resistance in Clinical presentation and diagnosis of diabetes mellitus in adults.
The brain is a hugely important organ which helps to be aware of, understand and interact with our surroundings and others.
As with many of our organs, the brain is susceptible to damage as a result of diabetes & brain
Diabetes foot care & management: Foot ulcers and amputations are a major cause of morbidity, disability, as well as emotional and physical costs for people with diabetes. Early recognition and management of independent risk factors for ulcers and amputations can prevent or delay the onset of adverse outcomes.
In Cardiac Resynchronization Therapy Arrhythmias are irregular heart rhythms and can be caused by a variety of reasons, including age, heart damage, medications and genetics. In heart failure patients CRT, or biventricular pacing, is used to help improve the heart’s rhythm and the symptoms associated with the arrhythmia.
Implantable Cardioverter Defibrillator An ICD is a battery-powered device placed under the skin that keeps track of your heart rate. Thin wires connect the ICD to your heart. If an abnormal heart rhythm is detected the device will deliver an electric shock to restore a normal heartbeat if your heart is beating chaotically and much too fast. It is important to understand that the decision to have angioplasty or coronary artery bypass graft (CABG) surgery to treat coronary artery disease (CAD) depends on many different things. A healthful eating pattern, regular physical activity, and often pharmacotherapy are key components of diabetes management. It is best to get vitamins and minerals from the foods you eat. In fact, research has not been able to prove that dietary or herbal supplements (including omega-3 supplements, cinnamon, and other herbs) help to manage diabetes.
Diabetes and its complications
Gastro paresis is a disorder affecting people with both type 1 and type 2 diabetes in which the stomach takes too long to empty its contents (delayed gastric emptying) Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in the blood vessels of the retina. Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar can injure nerve fibers throughout your body, but diabetic neuropathy most often damages nerves in your legs and feet. Currently, diabetic nephropathy is the leading cause of chronic kidney disease in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end-stage renal disease (ESRD) cases in the United States.
Cardiomyopathy is a condition where the heart muscle is abnormal. The main types of cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy. Cardiomyopathy makes it harder for your heart to pump and deliver blood to the rest of your body. Cardiomyopathy can lead to heart failure. Latent autoimmune diabetes in adults (LADA) is a disorder in which, despite the presence of islet antibodies at diagnosis of diabetes, the progression of autoimmune β-cell failure is slow.
Hypoglycemia is a medical emergency that involves an abnormally diminished content of glucose in the blood. Pregnant women who have never had diabetes before but who have high blood glucose (sugar) levels during pregnancy are said to have gestational diabetes. According to a 2014 analysis by the Centers for Disease Control and Prevention, the prevalence of euglycemia gestational diabetes conferences is as high as 9.2%. High blood pressure or hypertension increases the risk of heart disease and stroke. Hypertension risk factors include obesity, drinking too much alcohol, smoking, and family history. Beta-blockers are a common treatment for hypertension.
Advanced Technologies & Treatments for Diabetes
Blood glucose (blood sugar) monitoring is the main tool you have to check your diabetes control. This check tells you your blood glucose level at any one time. The artificial pancreas bridges the gap between two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). Relatively, a large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2. Insulin administration is essential for type 1 patients while it is required at later stage by the patients of type 2. Current insulin delivery systems are available as transdermal injections which may be considered as invasive. Several non-invasive approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections in order to improve patient compliance.
Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes
As a prognostic biomarker for progression of diabetic nephropathy, albuminuria fails in terms of sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which diabetic patients are at highest risk for progression. Bhensdadia et al. report proteomic investigations that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone. Excess adiposity is the most important risk factor for the development of insulin resistance and type 2 diabetes (1). However, mechanisms whereby body fat induces insulin resistance in distant tissues are not well understood. Recent evidence indicates that obesity may be an inflammatory markers.
Genetics of Diabetes
Several factors have to come together for a person to develop type 2 diabetes. Elements like nutrition and exercise are extremely important. However, type 2 diabetes also has a strong genetic component. Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetic risk for specific subtypes of diabetes
The burden of diabetes is much higher for racial/ethnic minorities than for whites. Minorities have a higher prevalence of diabetes than whites, and some minorities have higher rates of diabetes-related complications and death. Research results help in understanding these disparities and ways to reduce them.
Diabetes, the sixth leading cause of death in the United States, is a chronic disease characterized by persistent hyperglycemia (high blood glucose levels). ignificant advances have been made in recent years in relation to the pathogenesis of T2DM. This has significantly improved our knowledge of one of the most serious health threats in the world, allowing identification of genes and pathways involved in the development and progression of the disease. It has recently become possible to acquire molecular and genetic level information from an individual.
Emerging Focus in Diabetes Research
Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.
There are many risk factors for type 2 diabetes such as age, race, pregnancy, stress, certain medications, genetics or family history, high cholesterol and obesity. However, the single best predictor of type 2 diabetes is overweight or obesity. Almost 90% of people living with type 2 diabetes are overweight or have obesity. People who are overweight or have obesity have added pressure on their body's ability to use insulin to properly control blood sugar levels, and are therefore more likely to develop diabetes. The number of diabetes cases among American adults increased by a third during the 1990s, and additional increases are expected. This rapid increase in the occurrence of diabetes is mostly attributed to the growing prevalence of obesity in the United States.
The Bioinformatics/Computational Biology Service branch will provide basic capabilities to the Joslin Diabetes Center to analyze a wide range of high-throughput data. Housed on-site at the Joslin, the group and associated resources will be available to Joslin investigators and fellows who are either planning high-throughput experiments or need analysis of multi-scale data.
We prospectively followed 51,552 Finnish men and women 25–74 years of age without a history of Parkinson's disease at baseline. History of diabetes and other study parameters were determined at baseline using standardized measurements. Ascertainment of the Parkinson's disease status was based on the nationwide Social Insurance Institution's drug register data. Hazard ratios of incident Parkinson's disease associated with the history of type 2 diabetes were estimated. The entire spectrum of diabesity, including all of its complications–diabetes, elevated blood sugar, blood pressure, and cholesterol–are simply downstream symptoms that result from problems with diet, lifestyle, and environmental toxins interacting with our unique genetic susceptibilities. Bariatric surgery may be an option for adults with severe obesity. Body mass index (BMI), a measure of height in relation to weight, is used to define levels of obesity. Clinically severe obesity is a BMI > 40 or a BMI > 35 with a serious health problem linked to obesity. Such health problems could be type 2 diabetes, heart disease, or severe sleep apnea (when breathing stops for short periods during sleep).
Transplantation for Diabetes
In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin. Xenotransplantation is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants.
A transplant of the pancreas is usually reserved for those with serious complications. Pancreas transplants are most often done when a patient also receives a new kidney. Beta cell regeneration events pancreas transplant adds little further risk in this situation and offers big benefits. However, transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks.
Endocrinology: Disorders & Treatment
The endocrine system is a network of glands that produce and release hormones that help control many important body functions, especially the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.
Cell Therapy for Diabetes and Its Complications
Pancreatic β-cells are the target of an autoimmune assault in type 1 diabetes, with invasion of the islets by mononuclear cells in an inflammatory reaction termed “insulitis,” leading to loss of most β-cells after prolonged periods of disease.
Stem cells are essentially undifferentiated cells that can be induced into becoming specialized cells that are tissue- or organ-specific, according to the U.S. National Institutes of Health.
In some cases, such cells are sourced from embryonic tissue. Alternatively, it's possible to derive stem cells from prespecialized adult cells that are then reprogrammed to morph into an undifferentiated state. These are called induced pluripotent stem cells.
OMICS Group welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetes to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Dubai Diabetes Conference will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
The prevalence rates of diabetes in the Gulf region are among the highest in the world, with three countries in the Gulf region listed in the top ten and the UAE comes in at number 15. The awareness levels are slowly growing, but more needs to be done to educate the public, as well as the medical community. The 6th Global Diabetes Summit and Medicare Expo will be a three-day conference program dedicated to provide scientific and educational content for attendees looking at treatment options, as well as introducing a case study session, this conference aims to enhance diabetes care in the region. Dubai Diabetes Expo is perfect platform to join your colleagues including the most prestigious Speakers for exchanging ideas and Experience with your colleagues.
People with diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the heart and blood vessels, eyes, kidneys, nerves and teeth. In addition, people with diabetes also have a higher risk of developing infections. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation. The mission of the International Diabetes Federation is to promote diabetes care, prevention and a cure worldwide.
Diabetes clinical trial is a way to carefully test a new drug or device in patients before it is approved by the FDA to be used in the general public. Clinical trials are an important step in our being able to have new treatments for diabetes and other conditions.
Diabetes-2015 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes congress is where the future of management and novel therapeutics for the disease intersects.
Diabetes and obesity-related complications and associated metabolic disorders are major public health problems at the local, national and global levels. These metabolic defects underlie the basis for multiple debilitating diseases including heart disease, stroke, blindness, kidney disease, hypertension, neural degeneration, wound healing, amputations, periodontal disease and birth defects. World Diabetes Conference will address several cutting-edge aspects of molecular, cellular, tissue and integrative system metabolism that account for the metabolic defects that occur in diabetes and obesity. We organize Diabetes Expo in our conferences with-specific sessions reflect several key aspects of metabolic dysregulation in which novel information is currently forthcoming, causing a paradigm shift compared to our previous understanding of these processes. These include new information about tissue cross-talk, the inter-relationship between the control of glucose production and fatty acid synthesis that underlies selective insulin resistance and the role of normal and dysregulated circadian rhythms on metabolic processes. These cutting-edge advances will provide a foundation for identifying future research directions.
Having Diabetes symposiums in our conferences will bring together international scientists, physicians, and dietitians to showcase the latest advances from basic science to clinical trials in diabetes through plenary lectures, panel discussions. The theme of this year’s is, "Novel Approaches for Management of Diabetes and its clinical complications".
The exhibition is an integral part of the conference where up-to-date products and services are showcased for delegates. Diabetes Exhibitions provide information on the latest advances in technology, treatment options and services for healthcare professionals. Mass advertising may introduce your brand, but decision making in this space often hinges on the "diabetes dialogue"—an extensive exchange of questions and answers about diabetes, its management and potential product solutions.
Diabetes continues to be a global epidemic especially in the Middle East area where according to the Diabetes Association at least five countries from the Middle East area are among the top ten countries in prevalence of Diabetes either now or in the future up to the year 2030.The overarching goal of the Congress is to support the commitment of health care professionals in the Middle East in the fight against diabetes and their efforts on behalf of people with diabetes and their families.
The Guideline for Managing Older People with Type 2 Diabetes was considered a necessary development following the launch of the IDF 2012 Diabetes Guidelines for Type 2 Diabetes. In the latter, recommendations for managing diabetes in older people were included for the first time by the IDF.
The Diabetes workshops provides a unique opportunity for participants from a range of backgrounds including clinical, research and public health, to engage in discussion, debate and collaboration on prominent issues in diabetes epidemiology. It aims to provide all those attending with a common goal to become better equipped in the epidemiological and public health aspects of diabetes and helps to foster international networks.
The Emirates Diabetes Society is a non-profit medical society which was established in 1996 representing a cross section of specialist physicians and healthcare providers who are actively involved in the management of diabetes and endocrinology.
- Clinical Diabetes and Diagnostic Approaches
- Diabetes Management
- Diabetes and its Complications
- Advanced Technologies & Treatments for Diabetes
- Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes
- Genetics of Diabetes
- Emerging Focus in Diabetes Research
- Transplantation for Diabetes
- Endocrinology: Disorders & Treatment
- Cell Therapy for Diabetes and Its Complications
To share your views and research, please click here to register for the Conference.